Previous 10 | Next 10 |
home / stock / bioyf / bioyf news
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...
The following slide deck was published by BioSyent Inc. in conjunction with their 2020 Q2 earnings Read more ...
MISSISSAUGA, ON / ACCESSWIRE / August 24, 2020 / BioSyent Inc. ("BioSyent", "the Company", OTC PINK:BIOYF, TSX-V:RX.V) today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3 rd at 2:40 p.m. (ET). Mr. René Goehrum, President and CEO of BioS...
BioSyent ( OTCPK:BIOYF +0.3% ) reports Q4 revenue increase of 0.2% Y/Y to C$5.91M. More news on: BioSyent Inc. Read more ...
BioSyent ( OTCPK:BIOYF ): Q4 GAAP EPS of $0.11 beats by $0.03 . More news on: BioSyent Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
The following slide deck was published by BioSyent Inc. in conjunction with their 2018 Q3 earnings Read more ...
BioSyent ( OTCPK:BIOYF -5.5% ) reports Q3 revenue decrease of 3% Y/Y to C$5.26M. More news on: BioSyent Inc., Stocks on the move, Read more ...
BioSyent ( OTCPK:BIOYF ): Q3 GAAP EPS of C$0.09. Revenue of C$5.26M (-3% Y/Y) Press Release More news on: BioSyent Inc., Earnings news and commentary, Consumer stocks news, ,
The following slide deck was published by BioSyent Inc. in conjunction with their 2018 Q2 earnings Read more ...
BioSyent ( OTCPK:BIOYF ): Q2 GAAP EPS of C$0.11. More news on: BioSyent Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
MISSISSAUGA, Ontario, June 12, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. (“BioSyent Pharma”), has entered into an agreement with a Euro...
MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights include: Return on Equity for TTM March 31, 2024 was 21% as compared to 15% ...
MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on June 15, 20...